Diabetes exacerbates destructive inflammation by activating the CD137L-CD137 axis in dendritic and IL-17+ T cells
Diabetes verschlimmert destruktive Entzündung durch Aktivierung der CD137L-CD137-Achse in dendritischen und IL-17+-T-Zellen
Journal of Clinical Investigation · 02.02.2026 · 136 (3)
DOI: 10.1172/jci193289 ↗Auf einen Blick
Die Studie zeigt in Maus- und Humanbefunden: Hyperglykämie fördert eine CD137L-CD137-vermittelte Entzündung und Gewebedestruktion bei Parodontitis. Eine Blockade von CD137L verringerte Knochenverlust und Entzündungszellinfiltration.
Fragestellung
Wie verstärkt Diabetes die Entzündungsreaktion auf Bakterien bei Parodontitis?
Methode
Maus- und Humanstudien mit single-cell RNA-Seq, In-vitro-Kokultur und lineage-spezifischer Akt1-Deletion.
Ergebnisse
Hyperglykämie führte zu erhöhter CD137L-Expression in DCs und CD137 in IL-17+-T-Zellen. Die CD137L-Blockade reduzierte diabetesbedingten Knochenverlust, Neutrophilenrekrutierung, γδ-T-Zellen und IL-17A+-Zellinfiltration.
Schlussfolgerung der Autor:innen
Die Autor:innen sehen die CD137L-CD137-Achse als zentralen Mechanismus der diabetesbedingten Immunfehlregulation und Gewebeschädigung sowie als therapeutisches Ziel.
Kernaussagen
- Hyperglykämie erhöhte CD137L in DCs und CD137 in IL-17+-T-Zellen
- CD137L-Blockade senkte Knochenverlust und Entzündungszellinfiltration
- CD137-Aktivierung reproduzierte bei normalen Tieren die diabetesähnlichen Effekte
Deutsche Zusammenfassung: KI-gestützt aus dem Original-Abstract erstellt; alle Zahlen wurden automatisch mit dem Original abgeglichen. Maßgeblich ist der Original-Abstract.
Kurz gefasst
Fachartikel in der Zeitschrift Journal of Clinical Investigation, online erschienen am 11.12.2025. Verfasst von Xin Huang und 8 weiteren Autor:innen. Beteiligte Einrichtung: Hospital of Stomatology, Guanghua School of Stomatology and. Hauptthemen laut MEDLINE: Dendritic Cells, Tumor Necrosis Factor Receptor Superfamily, Member 9, Interleukin-17, 4-1BB Ligand. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 60 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIDCR NIH HHS, National Institute of Dental and Craniofacial Research of USA, National Science Foundation of China.
Themen: Diabetes mellitus
Abstract (Originalsprache)
Periodontal disease, a bacterial infection affecting a large percentage of the world’s population, is an important risk factor for several systemic diseases and is significantly worsened by diabetes. To investigate how diabetes exacerbates the inflammatory response to bacteria in this disease, we combined insights from murine and human studies. Through single-cell RNA-Seq, we identified a compelling hyperglycemia-driven molecular pathway: the upregulation of CD137L in dendritic cells (DCs) and increased expression of its receptor, CD137, in IL-17 + T cells. The CD137L-CD137 axis emerged as a pivotal mediator of diabetes-induced inflammatory tissue destruction. Antibody-mediated inhibition of CD137L markedly reduced diabetes-driven bone loss, neutrophil recruitment, expansion of γδ T cells, and excessive infiltration by IL-17A + cells. In vitro studies further validated these findings and established that dysregulation of DCs mediated by high glucose levels dramatically altered γδ T cell activity in co-culture systems via CD137L. The essential role of DCs as CD137L producers in vivo was definitively established through lineage-specific Akt1 deletion, which abrogated CD137L expression in DCs and reversed the adverse effects of hyperglycemia on increased IL-17 + T cells and loss of Tregs in vivo. Conversely, activation of CD137 with an agonist in normal animals recapitulated diabetes-induced abnormalities in the inflammatory response and accelerated bone loss. These findings elucidate a key mechanism underlying diabetes-induced immune dysregulation and inflammatory damage, and point to the CD137L-CD137 pathway as a promising therapeutic target, offering potential insights into mitigating other diabetes-associated complications linked to inflammatory changes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Hospital of Stomatology, Guanghua School of Stomatology and.
- Guangdong Provincial Key Laboratory of Stomatology, Sun Yat-sen University, Guangzhou, Guangdong, China.
- Department of Periodontics, School of Dental Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
- Center for Cytokine Storm Treatment & Laboratory and.
- Department of Pathology and Laboratory Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
Förderung
- NIDCR NIH HHS
- National Institute of Dental and Craniofacial Research of USA
- National Science Foundation of China
Zitieren
APA
Huang, X., Liu, M., Gonzalez, M. V., Debnath, R., Afzali, H., Choi, Y., Kim, S. A., Ko, K. I., & Graves, D. T. (2026). Diabetes exacerbates destructive inflammation by activating the CD137L-CD137 axis in dendritic and IL-17+ T cells. Journal of Clinical Investigation, 136(3). https://doi.org/10.1172/jci193289
Vancouver
Huang X, Liu M, Gonzalez MV, Debnath R, Afzali H, Choi Y, et al. Diabetes exacerbates destructive inflammation by activating the CD137L-CD137 axis in dendritic and IL-17+ T cells. Journal of Clinical Investigation. 2026;136(3). doi:10.1172/jci193289
BibTeX
@article{Huang2026,
author = {Huang, Xin and Liu, Min and Gonzalez, Michael V and Debnath, Rahul and Afzali, Hamideh and Choi, Yongwon and Kim, Su Ah and Ko, Kang I and Graves, Dana T},
title = {Diabetes exacerbates destructive inflammation by activating the CD137L-CD137 axis in dendritic and IL-17+ T cells},
journal = {Journal of Clinical Investigation},
year = {2026},
volume = {136},
number = {3},
doi = {10.1172/jci193289}
}
EUVIMED